Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis

Overview of attention for article published in Expert Review of Pharmacoeconomics and Outcomes Research, April 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs: 1 blog
twitter: 7 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Bibliosalut, 15 Jun 2022

#PublicaSalutIB Contribució del bimekizumab per al tractament de la psoriasi moderada a severa https://buff.ly/3NXUvii

Biblioteca de la Escuela Andaluza de Salud Pública, 09 May 2022

#Produccioncientifica Escuela Andaluza de Salud Pública Assessing the value contribution of bimekizumab for the treatment of…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.